Ignite Creation Date:
2024-05-05 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00391534
Status:
TERMINATED
Last Update Posted:
2010-04-15
First Post:
2006-10-23
Brief Title:
EXTENT EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy
Sponsor:
Desitin Arzneimittel GmbH
Organization:
Desitin Arzneimittel GmbH
Organization Data
Organization:
Desitin Arzneimittel GmbH
Class:
INDUSTRY
Study ID:
OXC-039K
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Desitin Arzneimittel GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Dr Martina Wangemann
Old Organization:
Desitin Arzneimittel GmbH
Collaborators
| Name | Class |
|---|---|
| FGK Clinical Research GmbH | INDUSTRY |